India has reported a record number of COVID-19 cases for the last five days in a row, with 352,991 cases reported April 25, according to CNBC.
The White House released a statement saying, “Just as India sent assistance to the United States as our hospitals were strained early in the pandemic, the United States is determined to help India in its time of need.”
The U.S. has identified sources of specific raw material urgently needed to make India’s COVID-19 vaccine that will be made available immediately, the statement said. The U.S. Development Finance Corporation is funding an expansion of manufacturing capability for India’s vaccine manufacturer, BioE, to enable the company to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022.
The U.S. has also identified supplies of therapeutics, rapid diagnostic test kits, ventilators and PPE that will be made immediately available to the country. It’s also “pursuing options to provide oxygen generation and related supplies on an urgent basis.”
Hospitals in India have been running out of oxygen, and in one case, 22 patients died in a hospital after a leak cut off their oxygen supplies, The New York Times reported.
Read the full White House statement here.
More articles on supply chain:
The PPE supply chain 1 year into the pandemic: 16 things to know
How Vermont is dealing with extra COVID-19 medical supplies
Blood shortage could delay surgeries at some California hospitals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.